India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) is pleased to announce the progress of its tetrahydrocannabinol (THC)-based phase 1 clinical trial, which was approved to...
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) today announced its financial results for the quarter ended December 31, 2020, which is the third quarter of its 2021 fiscal...
India Globalization Capital, Inc. (NYSE AMERICAN: IGC) announces that during its Annual Meeting of Shareholders scheduled for, and convened on January 11, 2021, voting on all matters as disclosed on the...
India Globalization Capital, Inc. (NYSE American: IGC), today announced that John E. Lynch has been nominated as a Class A independent director for election at the Company's 2020 Annual Meeting of Stockholders,...
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) announced that it is enrolling participants suffering from mild to severe dementia due to Alzheimer's disease for its Phase...
India Globalization Capital, Inc. ("IGC" or the "Company") (NYSE American: IGC) today announced its financial results for the quarter ended September 30, 2020, which is the second quarter of its 2021 fiscal...
India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended June 30, 2020, which is the first quarter of its 2021 fiscal year.
India Globalization Capital ("IGC" or the "Company") (NYSE American: IGC) announced today that on July 30, 2020, the U.S. Food and Drug Administration (FDA) notified IGC that it has authorized the Company...
India Globalization Capital, Inc. (the "Company") (NYSE: IGC) announces today the proposed settlement of three derivative lawsuits pending since 2018 and 2019 and provides notice to shareholders of the...
India Globalization Capital, Inc. (the "Company") (NYSE: IGC) recently received notification that on March 24, 2020, the United States Patent and Trademark Office ("USPTO") issued a method and composition...
India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended December 31, 2019, which is the third quarter of its 2020 fiscal year.
India Globalization Capital, Inc. (NYSE American: IGC) today announced financial results for the quarter ended September 30, 2019, which is the second quarter of its 2020 fiscal year.
India Globalization Capital, Inc. (NYSE: IGC) announced today that it has opened a marketing and research office in Colombia, South America. Hamsa Biochem SAS, a new beneficially owned subsidiary of IGC,...
India Globalization Capital, Inc. (NYSE: IGC) announced today that the Institutional Review Board ("IRB"), in Puerto Rico, approved its protocol for a double-blind, placebo-controlled, efficacy, safety...
India Globalization Capital, Inc. (NYSE American: IGC) today announced its financial results for the quarter ended June 30, 2019, which is the first quarter of its 2020 fiscal year.
Amneal Pharmaceuticals, Inc. (AMRX)
The booming cannabis industry has created opportunities for many driven entrepreneurs. In particular, many may be looking to launch something standard such as operating a retail dispensary or starting...
All over the world, the debate over cannabis' ability to replace traditional medicines goes on as more medicinal applications continue to emerge. A handful of countries have already adopted medical cannabis...
After the U.S. Farm Bill passed, CBD-based products have sprung up across the entire country. U.S. President Donald Trump signed the bill into effect in late 2018 after witnessing immense support pouring...
India Globalization Capital, Inc. (NYSE: IGC) announces that it will host educational conferences in two of the largest cities in Puerto Rico on April 27, 2019 (San Juan) and April 28, 2019...
